These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37022983)

  • 21. Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes.
    Fang Q; Shi J; Zhang J; Peng Y; Liu C; Wei X; Hu Z; Sun L; Hong J; Gu W; Wang W; Zhang Y
    Cardiovasc Diabetol; 2023 Jul; 22(1):167. PubMed ID: 37415203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Neuropathy, Glycemic Control, and Revascularization as Risk Factors for Future Lower Extremity Amputation among Diabetic Patients.
    Goldman MP; Corriere MA; Craven T; Davis RP; Sheehan M; Hurie JB; Velazquez G; Williams TK; Chang K; Edwards MS
    Ann Vasc Surg; 2021 May; 73():254-263. PubMed ID: 33248240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
    Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between visit-to-visit variability of glycated albumin and diabetic retinopathy among patients with type 2 diabetes - A prospective cohort study.
    Dai D; Shen Y; Lu J; Wang Y; Zhu W; Bao Y; Hu G; Zhou J
    J Diabetes Complications; 2021 Sep; 35(9):107971. PubMed ID: 34187717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes.
    Matsutani D; Sakamoto M; Minato S; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
    Cardiovasc Diabetol; 2018 Jul; 17(1):100. PubMed ID: 29991356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Long-Term Visit-to-Visit Hemoglobin A1c and Cardiovascular Risk in Type 2 Diabetes: The ACCORD Trial.
    Huang D; Huang YQ; Zhang QY; Cui Y; Mu TY; Huang Y
    Front Cardiovasc Med; 2021; 8():777233. PubMed ID: 34901237
    [No Abstract]   [Full Text] [Related]  

  • 28. Association of Both Short-term and Long-term Glycemic Variability With the Development of Microalbuminuria in the ACCORD Trial.
    Okuno T; Vansomphone A; Zhang E; Zhou H; Koska J; Reaven P; Zhou JJ
    Diabetes; 2023 Dec; 72(12):1864-1869. PubMed ID: 37725902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Significance of Long-term HbA
    Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
    Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial.
    Segar MW; Patel KV; Vaduganathan M; Caughey MC; Butler J; Fonarow GC; Grodin JL; McGuire DK; Pandey A
    Diabetes Care; 2020 Aug; 43(8):1920-1928. PubMed ID: 32540922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus.
    Hsu JC; Yang YY; Chuang SL; Yu CC; Lin LY
    Cardiovasc Diabetol; 2021 Jul; 20(1):148. PubMed ID: 34301257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between visit-to-visit HbA1c variability and the risk of cardiovascular disease in patients with type 2 diabetes.
    Shen Y; Zhou J; Shi L; Nauman E; Katzmarzyk PT; Price-Haywood EG; Horswell R; Bazzano AN; Nigam S; Hu G
    Diabetes Obes Metab; 2021 Jan; 23(1):125-135. PubMed ID: 32965068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels.
    D'Andrea E; Wexler DJ; Kim SC; Paik JM; Alt E; Patorno E
    JAMA Intern Med; 2023 Mar; 183(3):242-254. PubMed ID: 36745425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
    Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
    J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of hemoglobin A
    Lee A; Haddad D; Rybin D; Howell C; Ghaderi I; Berman S; Zhou W; Tan TW
    J Vasc Surg; 2021 Apr; 73(4):1332-1339.e5. PubMed ID: 32730894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visit-to-Visit Glucose Variability Predicts the Development of End-Stage Renal Disease in Type 2 Diabetes: 10-Year Follow-Up of Taiwan Diabetes Study.
    Yang YF; Li TC; Li CI; Liu CS; Lin WY; Yang SY; Chiang JH; Huang CC; Sung FC; Lin CC
    Medicine (Baltimore); 2015 Nov; 94(44):e1804. PubMed ID: 26554779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Diabetic Macular Edema and Cardiovascular Events in Type 2 Diabetes Patients: A Multicenter Observational Study.
    Leveziel N; Ragot S; Gand E; Lichtwitz O; Halimi JM; Gozlan J; Gourdy P; Robert MF; Dardari D; Boissonnot M; Roussel R; Piguel X; Dupuy O; Torremocha F; Saulnier PJ; Maréchaud R; Hadjadj S;
    Medicine (Baltimore); 2015 Aug; 94(33):e1220. PubMed ID: 26287408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Hemoglobin A1c Trajectories on Future Outcomes in a 10-Year Cohort With Type 2 Diabetes Mellitus.
    Ma C; Zhang W; Xie R; Wan G; Yang G; Zhang X; Fu H; Zhu L; Lv Y; Zhang J; Li Y; Ji Y; Gao D; Cui X; Wang Z; Chen Y; Yuan S; Yuan M
    Front Endocrinol (Lausanne); 2022; 13():846823. PubMed ID: 35450420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limb and cardiovascular event risk in type 1 and 2 diabetic patients with peripheral artery disease.
    Sykora D; Firth C; Girardo M; Tseng A; Wennberg P; Liedl D; Shamoun F
    Vasa; 2023 Sep; 52(5):310-316. PubMed ID: 37519117
    [No Abstract]   [Full Text] [Related]  

  • 40. Lower Extremity Amputation Rates in People With Diabetes Mellitus: A Retrospective Population Based Cohort Study in Zwolle Region, The Netherlands.
    Rosien L; van Dijk PR; Oskam J; Pierie MEN; Groenier KH; Gans ROB; Bilo HJG
    Eur J Vasc Endovasc Surg; 2023 Aug; 66(2):229-236. PubMed ID: 37220802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.